ASX ANNOUNCEMENT SEPTEMBER 2026 QUARTERLY ACTIVITIES REPORT AND APPENDIX 4C HIGHLIGHTS Closing cash balance of $22.3 million Strong first full quarter of combined trading 1 , generating $26.0 million in unaudited revenue and $4.4 million in net cashflow from operating activities Post-merger cost...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Little Green Pharma Ltd. on 6ix
Earlier from Little Green Pharma
- Implementation of Merger between LGP and Cannatrek
- Court Approves the Scheme and Scheme Becomes Effective
- Appendix 4E and 2026 Annual Report
- Transaction Update and General Meeting Update
- Updated second court date and indicative timetable
